CME and CFTC Clash Over On-Chain Perpetual Futures

The U.S. Commodity Futures Trading Commission's recent decision to allow the listing of blockchain-based perpetual futures products has ignited a heated dispute with the CME Group, the largest derivatives exchange operator in the country. The CME has filed a lawsuit against the CFTC, arguing that the regulator is mislabeling these products and thereby misapplying the law, as futures contracts are required to have an expiration date. The CME claims that perpetual futures, which enable traders to take a position on an asset's price without a deadline, are detrimental to its traditional futures products and that the CFTC's sudden approval of these products did not consider the potential consequences. The lawsuit has significant implications for the U.S. approach to the rapidly growing market of perpetual futures, with non-U.S. volume reportedly reaching $60 trillion last year. The CFTC's decision to allow the listing of crypto perpetual futures has been seen as a departure from its previous stance, and the regulator's chairman, Mike Selig, has been at the center of the controversy. The CME's lawsuit argues that the CFTC's approval of perpetual futures is a misapplication of the law, as these products do not meet the definition of a futures contract. The dispute has sparked a wider debate about the regulation of crypto derivatives and the role of the CFTC in overseeing the market. The outcome of the lawsuit is likely to have significant implications for the development of the U.S. crypto derivatives market and the balance of power between regulators and market participants.